Literature DB >> 19996920

Escaping from rejection.

Raymond J Lynch1, Jeffrey L Platt.   

Abstract

Since the earliest days of transplantation, immunobiologists have sought means to prevent recognition and rejection of foreign tissue. The goal of these strategies is the retention of recipient immune function while selectively avoiding graft injury. Although considerable theoretical and technical problems remain, an analogous problem and solution already exists in nature. Here, we discuss the mechanisms by which organisms preclude or control autotoxicity, and for each, consider the corollaries between prevention of autotoxicity and graft rejection. Further study of these controls, including structural and conditional tolerance and accommodation, will offer insight into new therapies for allo- and xenotransplantation.

Entities:  

Mesh:

Year:  2009        PMID: 19996920      PMCID: PMC2791908          DOI: 10.1097/TP.0b013e3181bcc93a

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  49 in total

1.  Is high titre ANA specific for connective tissue disease?

Authors:  J H Vaile; L Dyke; R Kherani; C Johnston; T Higgins; A S Russell
Journal:  Clin Exp Rheumatol       Date:  2000 Jul-Aug       Impact factor: 4.473

Review 2.  Transplantation of discordant xenografts: a review of progress.

Authors:  J L Platt; G M Vercellotti; A P Dalmasso; A J Matas; R M Bolman; J S Najarian; F H Bach
Journal:  Immunol Today       Date:  1990-12

3.  Sublytic complement attack protects tumor cells from lytic doses of antibody and complement.

Authors:  Y Reiter; A Ciobotariu; Z Fishelson
Journal:  Eur J Immunol       Date:  1992-05       Impact factor: 5.532

4.  COMBINATION OF BACTERIAL POLYSACCHARIDES AND COLLODION PARTICLES AS ANTIGENS.

Authors:  J Zozaya
Journal:  Science       Date:  1931-09-11       Impact factor: 47.728

5.  Heme oxygenase: protective gene or Trojan horse.

Authors:  J L Platt; K A Nath
Journal:  Nat Med       Date:  1998-12       Impact factor: 53.440

Review 6.  The epidemiology and significance of autoimmune diseases in health care.

Authors:  R Cervera
Journal:  Scand J Clin Lab Invest Suppl       Date:  2001

7.  Involvement of specific Lyt-2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis.

Authors:  R G Titus; G Milon; G Marchal; P Vassalli; J C Cerottini; J A Louis
Journal:  Eur J Immunol       Date:  1987-10       Impact factor: 5.532

8.  Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation.

Authors:  Xiaohu Fan; Andrew Ang; Stacey M Pollock-Barziv; Anne I Dipchand; Phillip Ruiz; Gregory Wilson; Jeffrey L Platt; Lori J West
Journal:  Nat Med       Date:  2004-10-24       Impact factor: 53.440

Review 9.  Molecular mechanisms of endotoxin tolerance.

Authors:  Hongkuan Fan; James A Cook
Journal:  J Endotoxin Res       Date:  2004

10.  Pituitary autoimmunity in patients with Sheehan's syndrome.

Authors:  Ravinder Goswami; Narayana Kochupillai; Patricia A Crock; Abdul Jaleel; Nandita Gupta
Journal:  J Clin Endocrinol Metab       Date:  2002-09       Impact factor: 5.958

View more
  5 in total

Review 1.  Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain.

Authors:  Esther S O'Sullivan; Arturo Vegas; Daniel G Anderson; Gordon C Weir
Journal:  Endocr Rev       Date:  2011-09-27       Impact factor: 19.871

Review 2.  Donor specific antibodies after transplantation.

Authors:  Jeffrey L Platt; Marilia Cascalho
Journal:  Pediatr Transplant       Date:  2011-03-29

Review 3.  Accommodation in renal transplantation: unanswered questions.

Authors:  Raymond J Lynch; Jeffrey L Platt
Journal:  Curr Opin Organ Transplant       Date:  2010-08       Impact factor: 2.640

Review 4.  Accommodation in ABO-incompatible organ transplants.

Authors:  Mayara Garcia de Mattos Barbosa; Marilia Cascalho; Jeffrey L Platt
Journal:  Xenotransplantation       Date:  2018-05       Impact factor: 3.907

Review 5.  Accommodation and related conditions in vascularized composite allografts.

Authors:  Jeffrey L Platt; Christina L Kaufman; Mayara Garcia de Mattos Barbosa; Marilia Cascalho
Journal:  Curr Opin Organ Transplant       Date:  2017-10       Impact factor: 2.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.